Events | 2022.04.19
CrossWork's Venture Fund Named “Best Pre-IPO Fund"; Expanding Life Sciences Advisory Board With Accomplished Medical Doctors, Scientists, And Industry Executives
CrossWork’s selective late-stage pre-IPO fund is adding a small number of highly accomplished senior medical doctors, biotech professionals, pharmaceutical executives, medical device executives, and other life sciences industry leaders to its specialist life sciences advisory board. CrossWork has a particular interest in senior medical doctors that serve on corporate advisory boards or have an interest therein. In addition to targeting cutting-edge medical investments including CRISPR gene editing and preventative medicine, CrossWork targets traditional pre-IPO investments in highly-established companies like SpaceX, Stripe, TikTok (Byte Dance), Discord, etc. Rather than focus on riskier, smaller startup companies, CrossWork focuses primarily on companies that already have revenues or valuation of over $1 billion.
(PRWeb April 19, 2022)
Read the full story at https://www.prweb.com/releases/2022/4/prweb18623510.htm
For more information, please visit
https://www.prweb.com/releases/2022/4/prweb18623510.htm
